The tweet was deleted by the author.
But we saved everything 🙂.
Access to mifepristone, a key medication used in reproductive care, will continue for women and their healthcare providers in the U.S. for now.
Melinda French expressed her relief at the continued availability of the drug, stating that access to safe and effective medication should not be subject to debate. She also emphasized her support for a woman's right to make decisions concerning her health and future.
View post on X Loading...
French previously commented on the critical role of mifepristone in U.S. women’s health. She has warned that restricting access to the drug could raise health risks for women. The ongoing debate has made the availability of mifepristone a focus for healthcare stakeholders.